FREQUENCY OF EPITHELIAL OVARIAN TUMOR AND ITS RISK FACTORS AMONG THE PATIENTS PRESENTING WITH OVARIAN TUMOR AT TERTIARY CARE HOSPITAL, KARACHI.
DOI:
https://doi.org/10.71000/zaj8fh35Keywords:
Epidemiology, Epithelial Ovarian Tumor, Menarche, Nulliparity, Obesity, Risk Factors, Tumor PrevalenceAbstract
Background: Epithelial ovarian tumors are among the most lethal gynecologic malignancies, often presenting at an advanced stage due to vague symptoms and lack of early detection strategies. These tumors account for the majority of ovarian cancer cases worldwide and pose a significant burden in low-resource settings. Identifying key risk factors in local populations is essential for improving diagnostic timing, shaping preventive strategies, and guiding targeted patient counseling and care.
Objective: To determine the frequency of epithelial ovarian tumors and assess the associated risk factors among patients presenting with ovarian tumors at a tertiary care hospital in Karachi.
Methods: This descriptive cross-sectional study was conducted at the Department of Obstetrics & Gynaecology, JPMC, Karachi, from February 19, 2022, to August 18, 2022. A total of 133 women aged 18–40 years presenting with ovarian tumors were enrolled through consecutive non-probability sampling. Informed consent was obtained. Demographic and clinical histories were recorded, including factors such as age, BMI, parity, reproductive history, hormone therapy use, and family history of malignancy. Data were analyzed using SPSS version 22. Frequencies, percentages, means, standard deviations, and chi-square tests were applied to assess associations, with p < 0.05 considered significant.
Results: The mean age was 43.02 ± 12.83 years. Epithelial ovarian tumors were observed in 106 (79.7%) participants. Risk factor distribution included: age ≥50 years in 46 (34.6%), BMI ≥30 in 30 (22.6%), nulliparity in 46 (34.6%), early menarche (<12 years) in 59 (44.4%), late menopause (>50 years) in 37 (27.8%), family or personal history of breast cancer in 4 (3.0%), ovarian cancer in 7 (5.3%), colon cancer in 2 (1.5%), hormone replacement therapy use in 8 (6.0%), and clomiphene use in 37 (27.8%).
Conclusion: Epithelial ovarian tumors are highly prevalent among women with ovarian masses. Early menarche, advancing age, and nulliparity emerged as the most frequent risk factors. These findings emphasize the need for awareness, early screening, and further studies to explore risk mitigation in high-risk groups.
Background: Epithelial ovarian tumors are among the most lethal gynecologic malignancies, often presenting at an advanced stage due to vague symptoms and lack of early detection strategies. These tumors account for the majority of ovarian cancer cases worldwide and pose a significant burden in low-resource settings. Identifying key risk factors in local populations is essential for improving diagnostic timing, shaping preventive strategies, and guiding targeted patient counseling and care.
Objective: To determine the frequency of epithelial ovarian tumors and assess the associated risk factors among patients presenting with ovarian tumors at a tertiary care hospital in Karachi.
Methods: This descriptive cross-sectional study was conducted at the Department of Obstetrics & Gynaecology, JPMC, Karachi, from February 19, 2022, to August 18, 2022. A total of 133 women aged 18–40 years presenting with ovarian tumors were enrolled through consecutive non-probability sampling. Informed consent was obtained. Demographic and clinical histories were recorded, including factors such as age, BMI, parity, reproductive history, hormone therapy use, and family history of malignancy. Data were analyzed using SPSS version 22. Frequencies, percentages, means, standard deviations, and chi-square tests were applied to assess associations, with p < 0.05 considered significant.
Results: The mean age was 43.02 ± 12.83 years. Epithelial ovarian tumors were observed in 106 (79.7%) participants. Risk factor distribution included: age ≥50 years in 46 (34.6%), BMI ≥30 in 30 (22.6%), nulliparity in 46 (34.6%), early menarche (<12 years) in 59 (44.4%), late menopause (>50 years) in 37 (27.8%), family or personal history of breast cancer in 4 (3.0%), ovarian cancer in 7 (5.3%), colon cancer in 2 (1.5%), hormone replacement therapy use in 8 (6.0%), and clomiphene use in 37 (27.8%).
Conclusion: Epithelial ovarian tumors are highly prevalent among women with ovarian masses. Early menarche, advancing age, and nulliparity emerged as the most frequent risk factors. These findings emphasize the need for awareness, early screening, and further studies to explore risk mitigation in high-risk groups.
References
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):7–33.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024 May;74(3):229-63.
Zheng L, Cui C, Shi O, Lu X, Li YK, Wang W, Li Y, Wang Q. Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990–2017. Gynecologic oncology. 2020 Oct 1;159(1):239-47.
Arora T, Mullangi S, Vadakekut ES, Lekkala MR. Epithelial ovarian cancer. InStatPearls [Internet] 2024 May 6. StatPearls Publishing.
Ali AT, Al-Ani O, Al-Ani F. Epidemiology and risk factors for ovarian cancer. Menopause Review/Przegląd Menopauzalny. 2023 Jun 14;22(2):93-104.
Ghose A, Bolina A, Mahajan I, Raza SA, Clarke M, Pal A, Sanchez E, Rallis KS, Boussios S. Hereditary ovarian cancer: towards a cost-effective prevention strategy. International journal of environmental research and public health. 2022 Sep 23;19(19):12057
Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno III DE, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MC. Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study. Cancers. 2022 Apr 29;14(9):2230.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Kim SY, Chang HK, Kwon O, Park J, Myong JP. Asbestos exposure and ovarian cancer: a meta-analysis. Safety and Health at Work. 2024 Mar 1;15(1):1-8.
Wentzensen N, O'Brien KM. Talc, body powder, and ovarian cancer: a summary of the epidemiologic evidence. Gynecologic oncology. 2021 Oct 1;163(1):199-208.
Mirzaei R, Bidgoli SA, Khosrokhavar R, Shoeibi S, Ashtiani HA. Increased risk of primary ovarian insufficiency by high-fructose diet consumption: a 90-day study in female rats. Environmental Science and Pollution Research. 2023 Jan;30(3):7415-26.
Zhang X, Ding HM, Deng LF, Chen GC, Li J, He ZY, Fu L, Li JF, Jiang F, Zhang ZL, Li BY. Dietary fats and serum lipids in relation to the risk of ovarian cancer: A meta-analysis of observational studies. Frontiers in Nutrition. 2023 Sep 14; 10:1153986.
Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, Alkatout I. The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Science Reports. 2022 Nov;5(6):e936.
Canlorbe G, Chabbert-Buffet N, Uzan C. Fertility-sparing surgery for ovarian cancer. Journal of Clinical Medicine. 2021 Sep 18;10(18):4235.
Song YJ. Prediction of optimal debulking surgery in ovarian cancer. Gland surgery. 2021 Mar;10(3):1173.
Wasim T, Mushtaq J, Wasim AZ. Gynecological malignancies at tertiary care hospital, Pakistan: A five-year review. Pakistan journal of medical sciences. 2021 May;37(3):621.
Liang X, Harris HR, Hendryx M, Shadyab AH, Hale L, Li Y, et al. Sleep Characteristics and Risk of Ovarian Cancer Among Postmenopausal Women. Cancer Prev Res (Phila). 2021;14(1):55-64.
Nieuwenhuis L, van den Brandt PA. Nut and peanut butter intake are not directly associated with the risk of endometrial or ovarian cancer: Results from a Dutch prospective cohort study. Clin Nutr. 2020;39(7):2202-10.
Xu Y, Jia Y, Zhang Q, Du Y, He Y, Zheng A. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis. Gynecol Oncol. 2021;160(2):610-8.
Toufakis V, Katuwal S, Pukkala E, Tapanainen JS. Impact of parity on the incidence of ovarian cancer subtypes: a population-based case-control study. Acta Oncol. 2021;60(7):850-5.
Turati F, Collatuzzo G, Di Maso M, Negri E, Esposito G, Alicandro G, et al. Fraction of cancers attributable to and prevented by reproductive factors and exogenous hormones use in Italy. Eur J Obstet Gynecol Reprod Biol. 2024;301:49-54.
Wang T, Jake-Schoffman DE, Townsend MK, Vinci C, Willett WC, Tworoger SS. Early life physical activity and risk of ovarian cancer in adulthood. Int J Cancer. 2021;149(12):2045-51.
Kang SY, Kim YJ, Kim S, Park HS. Different Patterns of the Relationship Between Gynecological Malignancy and Obesity Index: A Nationwide Retrospective Cohort Study in Korea. J Korean Med Sci. 2025;40(11):e31.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Shazia Naseeb, Haleema Shah (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.